NIT
ARRY

NumerixS Investment Technologies’s Array Biopharma Inc ARRY Stock Holding History

NumerixS Investment Technologies’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-300
Closed -$4K – 1442
2018
Q4 		$4K Buy
+300
New +$4.55K ﹤0.01% 1033
2017
Q3 		– Sell
-28,000
Closed -$234K – 1438
2017
Q2 		$234K Sell
28,000
-18,526
-40% -$152K 0.03% 592
2017
Q1 		$416K Buy
+46,526
New +$495K 0.05% 480
2016
Q1 		– Sell
-47,900
Closed -$202K – 1033
2015
Q4 		$202K Buy
47,900
+16,800
+54% +$76.7K 0.03% 696
2015
Q3 		$142K Sell
31,100
-50,200
-62% -$298K 0.02% 613
2015
Q2 		$586K Buy
+81,300
New +$600K 0.08% 315

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

NumerixS Investment Technologies's ARRY Position: Q1 2019 in Review

NumerixS Investment Technologies sold out of Array Biopharma Inc (ARRY) in Q1 2019, closing a stake of 300 shares — an estimated $4K sold.

NumerixS Investment Technologies first reported a position in ARRY in Q2 2015 and held it in 6 quarters. The position peaked at $586K in Q2 2015. 268 funds tracked by Wall St. Rank hold ARRY as of Q1 2019.

  • NumerixS Investment Technologies reported no remaining Array Biopharma Inc position as of Q1 2019 after selling out during the quarter.
  • NumerixS Investment Technologies sold 300 Array Biopharma Inc shares in Q1 2019, an estimated $4K.
  • NumerixS Investment Technologies first reported a position in Array Biopharma Inc in Q2 2015 and held it in 6 quarters.
  • NumerixS Investment Technologies's Array Biopharma Inc position peaked at $586K in Q2 2015.
  • 268 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q1 2019.

Based on NumerixS Investment Technologies's 13F filing for Q1 2019, filed 10 May 2019.